Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-19
2005-07-19
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S225200, C514S225800, C514S248000, C514S314000, C546S123000, C546S169000, C544S042000, C544S043000, C544S046000, C544S236000, C544S237000, C544S184000, C544S279000
Reexamination Certificate
active
06919351
ABSTRACT:
Aza- and polyaza-naphthalenyl carboxamide derivatives including certain quinoline carboxamide and naphthyridine carboxamide derivatives are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
REFERENCES:
patent: 3945995 (1976-03-01), Yamada et al.
patent: 4416884 (1983-11-01), Ishikawa et al.
patent: 4996213 (1991-02-01), Mendes et al.
patent: 5294620 (1994-03-01), Ratcliffe et al.
patent: 5633262 (1997-05-01), Hong et al.
patent: 5753666 (1998-05-01), Beasley et al.
patent: 5776944 (1998-07-01), Hong et al.
patent: 5945431 (1999-08-01), Jin et al.
patent: 6143760 (2000-11-01), Albaugh et al.
patent: 6211376 (2001-04-01), Romines et al.
patent: 6262055 (2001-07-01), Young et al.
patent: 6294547 (2001-09-01), Oka et al.
patent: 6306891 (2001-10-01), Selnick et al.
patent: 6380249 (2002-04-01), Young et al.
patent: 6525042 (2003-02-01), Kobayashi et al.
patent: WO 96/25399 (1996-08-01), None
patent: WO 98/11073 (1998-03-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO 99/10347 (1999-03-01), None
patent: WO 99/15526 (1999-04-01), None
patent: WO 99/32450 (1999-07-01), None
patent: WO 00/03992 (2000-01-01), None
patent: WO 01/00578 (2001-01-01), None
patent: WO 02/04443 (2002-01-01), None
patent: WO 02/06246 (2002-01-01), None
patent: WO 03/035076 (2003-05-01), None
patent: WO 03/035077 (2003-05-01), None
Parrill AL. Current Medicinal Chemistry. 2003, 10(18): 1811-24.
Zouhiri et al. J. Med. Chem. 2003, 43, 1533-1540.
Y. Pommier et al., “Retroviral Integrase Inhibitors Year 2000: Update and Perspectives”, 2000, pp. 532-565, vol. 47, Antiviral Research.
E. De Clercq et al., “New Anti-HIV Agents and Targets”, 2002, pp. 531-565, vol. 22, Medicinal Research Reviews.
D. J. Hazuda et al., “Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques”, 2004, pp. 528-532, vol. 305, Science.
D. J. Hazuda et al., “A Naphthyridine Carboxamide Provides Evidence for Discordant Resistance Between Mechanistically Indentical Inhibitors of HIV-1 Integrase”, 2004, pp. 11233-11238, vol. 101, No. 31, PNAS.
S. Bonnenfant et al., “Styrylquinolines, Integrase Inhibitors Acting Prior to Integration: a New Mechanism of Action for Anti-Integrase Agents”, 2004, pp. 5728-5736, vol. 78, No. 11, Journal of Virology.
A. L. Parrill et al., “HIV-1 Integrase Inhibition: Binding Sites, Structure Activity Relationships and Future Perspectives”, 2003, pp. 1811-1824, vol. 10, Current Medicinal Chemistry. (Full text).
L. Ratner et al., “Complete Nucleotide Sequence of the AIDS virus, HTLV III”, 1985, Nature, vol. 313, pp. 277-284.
H. Toh et al., “Close Structural Resemblance Between Putative Polymerase of a Drosophila Transposable Genetic Element 17.6 and Pol Gene Product of Moloney Murine Leukaemia Virus”, 1985, The EMBO Journal, vol. 4, No. 5, pp. 1267-1272.
M.D. Power et al., “Nucleotide Sequence of SRV-1, Type D Simian Acquired Immune Deficiency Syndrome Retrovirus”, 1986, Science, vol. 231, pp. 1567-1572.
L.H. Pearl et al., “A Structural Model for the Retroviral Process”, 1987, Nature, vol. 329, pp. 351-354.
L. Chan et al., “Discovery of 1,6-Naphthyridines as a Novel Class of Potent and Selective Human Cytomegalovirus Inhibitors”, 1999, J. Med. Chem., vol. 42, No. 16, pp. 3023-3025.
M. Ouali et al., “Modeling of the Inhibition of Retroviral Integrases by Styrylquinoline Derivatives”, 2000, J. Med. Chem., vol. 43, pp. 1949-1957.
Derwent Abstract No. 97-048296/05, 1997 (Abstract of JP 08301849-A, Takeda Chem. Ind. Ltd., “New Heterocyclic Carboxamide Derivs.-Useful in Pharmaceuticals as Tachykinin Receptor Inhibitors”).
Chemical Abstracts No. 33-2525, 1938 (Abstract of Otiai et al., “Synthesis of 2.5 Naphthyridine Derivatives, II”, J. Pharm, Soc. Japan, vol. 58, pp. 764-770).
CAPLUS Accession No. 2001:923611, 2001, Kiyama et al., (Abstract of WO 01/95905, Assignee: Shionogi & Co., Ltd., “Dual Divalent Metal Ion Chelators as HIV Integrase Inhibitors”).
Derwent Abstract No. 2002-732783,2002 (Abstract of WO 02/070491, Fuji, M., “New Nitrogenous Heteroaromatic Compounds are HIV Integrase Inhibitors for Treating HIV Infections, AIDS and AIDS Related Diseases”.
IPDL Abstract of WO 02/070486, Shionogi & Co., Ltd., Fuji et al., “Nitrogen- Containing Heteroaryl Compounds Having HIV Integrase Inhibitory Activity”).
J. Bedard et al., “Antiviral Properties of a Series of 1,6-Naphthyridine and 7,8-Dihyroisoquinoline Derivatives Exhibiting Potent Activity Against Human Cytomegalovirus”, 2004, vol. 44, Antimicrobial Agents and Chemotherapy.
Anthony Neville J.
Bennett Jennifer J.
Egbertson Melissa S.
Gomez Robert P.
Wai John S.
Camara Valerie J.
Huang Evelyn Mei
Merck & Co. , Inc.
Walton Kenneth R.
LandOfFree
Aza-and polyaza-naphthalenyl-carboxamides useful as HIV... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aza-and polyaza-naphthalenyl-carboxamides useful as HIV..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aza-and polyaza-naphthalenyl-carboxamides useful as HIV... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3390594